Trinity Life Sciences Acquires CBPartners

October 7, 2021

Trinity Life Sciences has acquired New York–headquartered CBPartners to significantly scale its Value, Access and Pricing business, adding over 75 dedicated experts and expanding Trinity's presence in New York City, San Francisco and London. The acquisition augments Trinity's market access, pricing and commercial strategy capabilities to better support life sciences companies in bringing products to market and ensuring patient access globally.

Targets
CBPartners
Location
New York, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.